TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy

Cell Metabolism - United States
doi 10.1016/j.cmet.2018.09.020
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Targeting Treg Cells in Cancer Immunotherapy

European Journal of Immunology
AllergyImmunology
2019English

Metabolic Control of the Treg/Th17 Axis

Immunological Reviews
AllergyImmunology
2013English

Metabolic Control of Regulatory T Cell (Treg) Survival and Function by Lkb1

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

The Role of PD-1/PD-L1 Axis in Treg Development and Function: Implications for Cancer Immunotherapy

OncoTargets and Therapy
OncologyPharmacology
2019English

Optimizing Human Treg Immunotherapy by Treg Subset Selection and E-Selectin Ligand Expression

Scientific Reports
Multidisciplinary
2018English

ICOS-L as a Potential Therapeutic Target for Cancer Immunotherapy

Current Protein and Peptide Science
MedicineBiochemistryCell BiologyMolecular Biology
2018English

Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

B7-H3, a Checkpoint Molecule, as a Target for Cancer Immunotherapy

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2020English

Utilizing Cytokines to Function-Enable Human NK Cells for the Immunotherapy of Cancer

Scientifica
AgriculturalEnvironmental ScienceBiological Sciences
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy